REDWOOD CITY, Calif., Oct. 25 /PRNewswire-FirstCall/ -- Cardica, Inc. today announced that it will release financial results for its fiscal 2007 first quarter ended September 30, 2006 on Wednesday, November 1, 2006 after the markets close, and management will host a conference call at 4:30 p.m. Eastern Time that day.
Conference Call Details
To access the live conference call on November 1, 2006 at 4:30 p.m. Eastern Time via phone, please dial (800) 561-2718 from the United States and Canada or (617) 614-3525 internationally. The conference ID is 87504462. Please dial in approximately ten minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through Wednesday, November 8, 2006 and may be accessed by dialing (888) 286-8010 from the United States and Canada or (617) 801-6888 internationally. The replay passcode is 90685040.
To access the live and subsequently archived webcast of the conference call, go to the Investor Relations section of the Company's website at www.cardica.com. Please connect to the web site at least 15 minutes prior to the call to allow for any software download that may be necessary.
The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents (www.streetevents.com), a password-protected event management site.
About Cardica, Inc.
Cardica designs and manufactures automated anastomosis systems for coronary artery bypass graft (CABG) surgery. By replacing hand-sewn sutures with easy-to-use automated systems, Cardica provides cardiovascular surgeons with rapid, reliable and consistently reproducible anastomoses, or connections of blood vessels, often considered the most critical aspect of the CABG procedure.
Cardica's C-Port(R) Distal Anastomosis System is marketed in Europe and the United States. The PAS-Port(R) Proximal Anastomosis System is marketed in Europe and Japan and is being evaluated in a pivotal trial in the United States and Europe. Cardica also is developing additional devices to facilitate vascular and other surgical procedures. Go to www.cardica.com for more information.
Cardica, Inc.CONTACT: Bob Newell, Vice President, Finance and Operations, ChiefFinancial Officer of Cardica, Inc., +1-650-331-7166, orinvestors@cardica.com; or Daryl Messinger of WeissComm Partners, Inc.,+1-415-999-2361, or daryl@weisscommpartners.com
Web site: http://www.cardica.com/
